Screening for prostate cancer remains controversial

MeSH terms

• Costs and Cost Analysis
• Early Detection of Cancer
• Humans
• Male
• Mass Screening / standards
• Middle Aged
• Patient Selection
• Practice Guidelines as Topic*
• Prostate-Specific Antigen / blood*
• Prostatic Neoplasms / diagnosis*
• Prostatic Neoplasms / mortality
• Prostatic Neoplasms / therapy
• Quality-Adjusted Life Years
• Randomized Controlled Trials as Topic
• Risk Factors
• Sensitivity and Specificity
• Treatment Outcome